U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  1. Home

Vaccines

Image
Bottles of Vaccine Vials

Vaccines, as with all products regulated by FDA, undergo a rigorous review of laboratory and clinical data to ensure the safety, efficacy, purity and potency of these products. Vaccines approved for marketing may also be required to undergo additional studies to further evaluate the vaccine and often to address specific questions about the vaccine's safety, effectiveness or possible side effects.

According to the Centers for Disease Control and Prevention, vaccines have reduced preventable infectious diseases to an all-time low and now few people experience the devastating effects of measles, pertussis and other illnesses.

The Center for Biologics Evaluation and Research (CBER) regulates vaccine products. Many of these are childhood vaccines that have contributed to a significant reduction of vaccine-preventable diseases.

Vaccine Information

Vaccine Safety & Availability

Counterterrorism

Pandemic

Seasonal Information


Related Information

 

Resources for You
Recalls & Alerts
Approvals & Clearances

Sub-Topic Paragraphs

Title
Follow CBER

Contact Point

Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Center for Biologics Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave WO71-3103
Silver Spring, MD 20993-0002

(800) 835-4709
(240) 402-8010

Hours Available

Food and Drug Administration
Food and Drug Administration
White Oak Campus

10903 New Hampshire Ave

Silver Spring, MD 20993
United States


For Updates on Twitter follow

Contact Point Twitter

@fdacber

The latest information from the Center for Biologics Evaluation and Research.


Subscribe for CBER Updates

Get e-mail updates on What’s New at CBER!